139 related articles for article (PubMed ID: 16446405)
1. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation.
Shi M; Cooper JC; Yu CL
Mol Cancer Res; 2006 Jan; 4(1):39-45. PubMed ID: 16446405
[TBL] [Abstract][Full Text] [Related]
2. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
Cooper JC; Boustead JN; Yu CL
Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
[TBL] [Abstract][Full Text] [Related]
3. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway.
Brockdorff J; Nielsen M; Kaltoft K; Mustelin T; Röpke C; Svejaard A; Geisler C; Odum N
Eur Cytokine Netw; 2000 Jun; 11(2):225-31. PubMed ID: 10903801
[TBL] [Abstract][Full Text] [Related]
4. Growth transformation of human T cells by herpesvirus saimiri requires multiple Tip-Lck interaction motifs.
Heck E; Friedrich U; Gack MU; Lengenfelder D; Schmidt M; Müller-Fleckenstein I; Fleckenstein B; Ensser A; Biesinger B
J Virol; 2006 Oct; 80(20):9934-42. PubMed ID: 17005671
[TBL] [Abstract][Full Text] [Related]
5. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.
Kazansky AV; Rosen JM
Cell Growth Differ; 2001 Jan; 12(1):1-7. PubMed ID: 11205741
[TBL] [Abstract][Full Text] [Related]
6. The heterotrimeric G-protein alpha-subunit Galphaq regulates TCR-mediated immune responses through an Lck-dependent pathway.
Ngai J; Methi T; Andressen KW; Levy FO; Torgersen KM; Vang T; Wettschureck N; Taskén K
Eur J Immunol; 2008 Nov; 38(11):3208-18. PubMed ID: 18991294
[TBL] [Abstract][Full Text] [Related]
7. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
Yamashita H; Iwase H; Toyama T; Fujii Y
Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Lck tyrosine protein kinase by the Herpesvirus saimiri tip protein involves two binding interactions.
Hartley DA; Amdjadi K; Hurley TR; Lund TC; Medveczky PG; Sefton BM
Virology; 2000 Oct; 276(2):339-48. PubMed ID: 11040125
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Bcl-3 through interaction with the Lck tyrosine kinase.
Zhao Y; Ramakrishnan A; Kim KE; Rabson AB
Biochem Biophys Res Commun; 2005 Sep; 335(3):865-73. PubMed ID: 16099425
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of an activated form of the protein tyrosine kinase Lck from an Escherichia coli expression system.
Flint NA; Amrein KE; Jascur T; Burn P
J Cell Biochem; 1994 Jul; 55(3):389-97. PubMed ID: 7962172
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
Amorino GP; Deeble PD; Parsons SJ
Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.
Yu CL; Jove R; Burakoff SJ
J Immunol; 1997 Dec; 159(11):5206-10. PubMed ID: 9548458
[TBL] [Abstract][Full Text] [Related]
15. Activation of Lck is critically required for sphingosine-induced conformational activation of Bak and mitochondrial cell death.
Kim MJ; Park MT; Yoon CH; Byun JY; Lee SJ
Biochem Biophys Res Commun; 2008 May; 370(2):353-8. PubMed ID: 18371298
[TBL] [Abstract][Full Text] [Related]
16. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
17. Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591.
Vempati S; Reindl C; Wolf U; Kern R; Petropoulos K; Naidu VM; Buske C; Hiddemann W; Kohl TM; Spiekermann K
Clin Cancer Res; 2008 Jul; 14(14):4437-45. PubMed ID: 18628457
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death.
Hollmann CA; Owens T; Nalbantoglu J; Hudson TJ; Sladek R
Cancer Res; 2006 Apr; 66(7):3550-7. PubMed ID: 16585179
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphorylated TCR/CD3zeta signals through a Grb2-SOS1-Ras pathway in Lck knockdown cells.
Methi T; Ngai J; Vang T; Torgersen KM; Taskén K
Eur J Immunol; 2007 Sep; 37(9):2539-48. PubMed ID: 17683112
[TBL] [Abstract][Full Text] [Related]
20. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]